BlackRock Fund Advisors’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
BIT
RSCM
EAM
CS
BlackRock Fund Advisors's TTPH Position: Q4 2016 in Review
BlackRock Fund Advisors reduced its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 20% in Q4 2016, selling an estimated $1.2M and leaving 61,099 shares worth $4.92M. The position accounts for ﹤0.01% of the portfolio, ranked #2943.
BlackRock Fund Advisors first reported a position in TTPH in Q2 2013 and has held it in 15 quarters since. The position peaked at $63M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q4 2016.
- BlackRock Fund Advisors held 61,099 shares of Tetraphase Pharmaceuticals, Inc. worth $4.92M as of Q4 2016.
- BlackRock Fund Advisors sold 15,208 Tetraphase Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.2M.
- Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2943 holding.
- BlackRock Fund Advisors first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
- BlackRock Fund Advisors's Tetraphase Pharmaceuticals, Inc. position peaked at $63M in Q2 2015.
- 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.